 |
|
|
| |
Patients with HBeAg-positive chronic hepatitis B with a maintained virologic response to entecavirachieved HBsAg clearance when switched to peginterferon alfa-2a (40KD) therapy (the OSST study)
|
| |
| |
Reported by Jules Levin
AASLD Nov 5-8 2011 SF
Q. Ning,1 M.F. Han,1 Y.T. Sun,2 J.J. Jiang,3 D.M. Tan,4 J.L. Hou,5 H. Tang,6 J.F. Sheng,7 M. Jiang8
1Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, China; 2Tangdu Hospital, the Fourth Military Medical University, China; 3The First Hospital, Fujian Medical University, China; 4Xiangya Hospital, Central South University, China; 5Nanfang Hospital, Nanfang Medical University, China; 6Huaxi Hospital, Sichuan University, China; 7The First Hospital, Zhejiang University, China; 8formerly of Roche Pharmaceutical Co. Ltd., Shanghai, China
|
| |
|
|
|
|
|
